CD163- | CD163+ | % CD163+ | ||||||
---|---|---|---|---|---|---|---|---|
n | Control | APP-infected | Control | APP-infected | Control | APP-infected | ||
Bone marrow | 5 | 1571 ± 118 | 464 ± 83** | 1020 ± 161 | 1430 ± 142 | 38.6 ± 2.7 | 75.2 ± 4.3** | |
Peripheral blood | 5 | 418 ± 61 | 184 ± 44* | 418 ± 111 | 1142 ± 255* | 47.1 ± 6.9 | 86.2 ± 0.5** | |
Spleen | 4 | 3009 ± 916 | 1052 ± 273* | 3524 ± 1,043 | 10 886 ± 3359 | 54.8 ± 9.6 | 90.0 ± 1.8* | |
Lungs | Unaffected area | 5 | 1459 ± 336 | 735 ± 225* | 3384 ± 702 | 7555 ± 1493* | 69.0 ± 7.4 | 90.9 ± 2.1** |
Demarcation zone | 4 | 985 ± 467 | 11 890 ± 4331 | 90.4 ± 3.8* | ||||
Necrotic area | 5 | 2873 ± 1,441 | 5948 ± 2232 | 66.2 ± 6.0 | ||||
Tracheobronchial LN | 5 | n.d. | 1547 ± 674* | n.d. | 16 563 ± 4284* | n.d. | 92.9 ± 1.7 | |
Mesenteric LN | 4 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |